Unique ID issued by UMIN | UMIN000037954 |
---|---|
Receipt number | R000042143 |
Scientific Title | Effects of Community Pharamcists' Medication Assisst for the Patients Taking Antihypertensives |
Date of disclosure of the study information | 2019/09/10 |
Last modified on | 2022/04/11 11:11:50 |
Effects of Community Pharamcists' Medication Assisst for the Patients Taking Antihypertensives
Effects of Community Pharamcists' Medication Assisst for the Patients Taking Antihypertensives
Effects of Community Pharamcists' Medication Assisst for the Patients Taking Antihypertensives
Effects of Community Pharamcists' Medication Assisst for the Patients Taking Antihypertensives
Japan |
Depression
Psychosomatic Internal Medicine |
Others
NO
Determine whether medication support based on cognitive behavioral therapy by pharmacy pharmacists improves adherence for patients taking antidepressants.
Efficacy
Confirmatory
Pragmatic
Medication Adherence during the intervention period (6 months)
QOL, Cost-effectiveness, Severity of the disease, The relationship between pharmacists and patients
Interventional
Parallel
Non-randomized
Open -no one is blinded
Placebo
NO
NO
Institution is considered as a block.
YES
Central registration
2
Educational,Counseling,Training
Other |
Medication support based on cognitive behavioral therapy
Medication consultation by phone
20 | years-old | <= |
75 | years-old | >= |
Male and Female
Patients diagnosed with depression
Dementia, bipolar, schizophrenia, patients who have difficulty in answering questionnaires
60
1st name | Mitsuko |
Middle name | |
Last name | Onda |
Osaka University of Pharmaceutical Sciences
laboratory of Social and Administrative Pharmacy
569-1094
4-20-1, Nasahara Takatsuki, Osaka, Japan
072-690-1059
onda@gly.oups.ac.jp
1st name | Masaki |
Middle name | |
Last name | Shoji |
Osaka University of Pharmaceutical Sciences
laboratory of Social and Administrative Pharmacy
569-1094
4-20-1, Nasahara Takatsuki, Osaka, Japan
072-690-1059
shoji@gly.oups.ac.jp
Osaka University of Pharmaceutical Sciences
Public Interest Incorporated Foundation The Health Care Science Institute
Self funding
Osaka University of Pharmaceutical Sciences, Research Ethics Committee
4-20-1, Nasahara Takatsuki, Osaka, Japan
072-690-1103
kenkyus@gly.oups.ac.jp
NO
2019 | Year | 09 | Month | 10 | Day |
Unpublished
31
Nineteen participants in the intervention group and 12 in the control group completed the study. The intervention group tended to have higher DAI-10 scores (dIG: 1.059, dCG: -2.000; p=0.035) and PHQ-9 scores (dIG: 0.813, dCG: -2.818; p=0.049)than the control group
2020 | Year | 09 | Month | 07 | Day |
Delay expected |
Due to a delay in recruitment.
At the beginning of the study, 25 participants were enrolled in the IG and 14 in the CG; however, six participants from the IG and two from the CG dropped out of the study during follow-up. Nineteen participants in the IG and 12 in the CG completed the study.
No adverse events have been reported as a result of this study.
Drug Attitude Investigator(DAI)-10,
Patient Health Questionnaire(PHQ)-9,
EQ-5D5L,
Patient Satisfaction,
The pharmacists' confidence scale about medication consultation for depressive patients(PCMCD)
Main results already published
2019 | Year | 06 | Month | 03 | Day |
2018 | Year | 10 | Month | 04 | Day |
2019 | Year | 06 | Month | 17 | Day |
2020 | Year | 03 | Month | 12 | Day |
2020 | Year | 06 | Month | 01 | Day |
2019 | Year | 09 | Month | 06 | Day |
2022 | Year | 04 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042143
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |